Brief: Sprint Bioscience Q2 Operating Result Swings To Loss Of SEK 9.7 Mln
15/08/2018 07:37
Aug 15 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 REVENUE SEK 2.9 MILLION VERSUS SEK 11.5 MILLION YEAR
AGO
* Q2 OPERATING LOSS SEK 9.7 MILLION VERSUS PROFIT SEK 1.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrb8xPRy
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln